Last checked at 
NetScientific PLC - life sciences and technology investment and commercialisation company - Says portfolio company ProAxsis Ltd appoints DiaPharma Group Inc as exclusive distributor of its portfolio of respiratory research assays for key North America region. Partnership agreement provides DiaPharma exclusive access to ProAxsis' activity-based immunoassay kits for the quantification of the active forms of neutrophil elastase, proteinase 3 and cathepsin G.
Current stock price: 58.10 pence
Year-to-date change: down 14%
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.